Evidence map›Paper›PMID 34379308›Full record

ArticleInfection2022

In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.

Paul R Wratil, Niklas A Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech, Burak Karakoc, Mira Zeilberger, Julius Steffen, Tonina T Mueller, Patricia M Spaeth and 13 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 3 countries.

Paul R Wratil *Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany. wratil@mvp.lmu.de.ORCID https://orcid.org/0000-0003-0942-0637
Niklas A Schmacke *Department of Biochemistry and Gene Center, LMU München, Munich, Germany.ORCID https://orcid.org/0000-0002-3998-1139
Andreas Osterman *Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
Tobias WeinbergerDepartment of Medicine I, University Hospital, LMU München, Munich, Germany.
Jochen RechDepartment of Biochemistry and Gene Center, LMU München, Munich, Germany.
Burak KarakocFaculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
Mira ZeilbergerDepartment of Medicine IV, University Hospital, LMU München, Munich, Germany.
Julius SteffenDepartment of Medicine I, University Hospital, LMU München, Munich, Germany.
Tonina T MuellerDepartment of Medicine I, University Hospital, LMU München, Munich, Germany.
Patricia M SpaethFaculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
Marcel SternFaculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
Manuel AlbaneseFaculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany.
Hella ThunDepartment of Communication and Media, University Hospital, LMU München, Munich, Germany.
Julia ReinboldDepartment of Communication and Media, University Hospital, LMU München, Munich, Germany.
Benedikt SandmeyerInstitute of Emergency Medicine and Management in Medicine, University Hospital, LMU Munich, Munich, Germany.
Philipp KressirerDepartment of Communication and Media, University Hospital, LMU München, Munich, Germany.
Béatrice GrabeinDepartment for Clinical Microbiology and Hospital Hygiene, University Hospital, LMU München, Munich, Germany.
Peter FalkaiDepartment of Psychiatry and Psychotherapy, University Hospital, LMU München, Munich, Germany.
Kristina AdorjanDepartment of Psychiatry and Psychotherapy, University Hospital, LMU München, Munich, Germany.
Veit HornungDepartment of Biochemistry and Gene Center, LMU München, Munich, Germany.
Lars KaderaliInstitute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.
Matthias Klein *Emergency Department and Department of Neurology, University Hospital, LMU München, Munich, Germany.
Oliver T Keppler *Faculty of Medicine, National Reference Center for Retroviruses, Max Von Pettenkofer Institute and Gene Center, Virology, LMU München, Munich, Germany. keppler@mvp.lmu.de.ORCID https://orcid.org/0000-0002-1384-8946
LMU Klinikum · DELudwig-Maximilians-Universität München · DEDepartment of Virology · FRLaboratoire National de Référence · MAUniversitätsmedizin Greifswald · DE

Funding

bundesministerium für bildung und forschung 01KX2021
6 · The paper itself

Abstract

purposeTo determine risk factors for coronavirus disease 2019 (COVID-19) in healthcare workers (HCWs), characterize symptoms, and evaluate preventive measures against SARS-CoV-2 spread in hospitals.

methodsIn a cross-sectional study conducted between May 27 and August 12, 2020, after the first wave of the COVID-19 pandemic, we obtained serological, epidemiological, occupational as well as COVID-19-related data at a quaternary care, multicenter hospital in Munich, Germany.

results7554 HCWs participated, 2.2% of whom tested positive for anti-SARS-CoV-2 antibodies. Multivariate analysis revealed increased COVID-19 risk for nurses (3.1% seropositivity, 95% CI 2.5-3.9%, p = 0.012), staff working on COVID-19 units (4.6% seropositivity, 95% CI 3.2-6.5%, p = 0.032), males (2.4% seropositivity, 95% CI 1.8-3.2%, p = 0.019), and HCWs reporting high-risk exposures to infected patients (5.5% seropositivity, 95% CI 4.0-7.5%, p = 0.0022) or outside of work (12.0% seropositivity, 95% CI 8.0-17.4%, p < 0.0001). Smoking was a protective factor (1.1% seropositivity, 95% CI 0.7-1.8% p = 0.00018) and the symptom taste disorder was strongly associated with COVID-19 (29.8% seropositivity, 95% CI 24.3-35.8%, p < 0.0001). An unbiased decision tree identified subgroups with different risk profiles. Working from home as a preventive measure did not protect against SARS-CoV-2 infection. A PCR-testing strategy focused on symptoms and high-risk exposures detected all larger COVID-19 outbreaks.

conclusionAwareness of the identified COVID-19 risk factors and successful surveillance strategies are key to protecting HCWs against SARS-CoV-2, especially in settings with limited vaccination capacities or reduced vaccine efficacy.

Indexed as

COVID-19Cross-Sectional StudiesHealth PersonnelHumansMalePandemicsRisk FactorsSARS-CoV-2COVID-19Healthcare workersPreventionRisk factorsSARS-CoV-2

Identifiers

PMID34379308
PMCPMC8354838
OpenAlexW3191541594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.